Aims Male breast cancer incidence is 1% of all breast cancers and is increasing. We aim to
present an overview of male breast cancer with particular emphasis on clinical …

Abstract Purpose of Review Male breast cancer is a relatively uncommon and rare disease
that is often managed based on evidence adopted from trials pertaining to female breast …

Background The male breast cancer (MBC) is a rare and represents less than 1% of all
malignancies in men and only 1% of all breast cancers incident. We illustrate the experience …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. Due to the low incidence, there are no randomized clinical studies giving …

Objective Male breast cancer (BC) is a rare disease, having different clinicopathological
features and survival outcomes from female patients. The aim of this research was to …

Introduction Although a substantial proportion of male breast cancers (MBCs) are hereditary,
the molecular pathways that are activated are unknown. We therefore examined the …

Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …

Background Male breast cancer (MBC) is rare; however, its incidence is increasing. There
have been no large-scale reports on the clinicopathological characteristics of MBC in Japan …

Introduction Male breast carcinoma (MBC) is treated similarly to female breast carcinoma
(FBC), and similar survival rates for both have been assumed. We analyzed prognostic and …

Male breast cancer (MBC) is a rare disease. However, as global populace ages, there is a
trend to MBC increasing. Although aetiology is still unclear, constitutional, environmental …